tradingkey.logo

Picard Medical Inc

PMI
1.880USD
+0.180+10.65%
Close 02/06, 16:00ETQuotes delayed by 15 min
138.56MMarket Cap
LossP/E TTM

Picard Medical Inc

1.880
+0.180+10.65%

More Details of Picard Medical Inc Company

Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

Picard Medical Inc Info

Ticker SymbolPMI
Company namePicard Medical Inc
IPO dateAug 29, 2025
CEOSchnegelsberg (Patrick N.J)
Number of employees75
Security typeOrdinary Share
Fiscal year-endAug 29
Address1992 E. Silverlake Rd.
CityTUCSON
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code85713
Phone15203080796
Website
Ticker SymbolPMI
IPO dateAug 29, 2025
CEOSchnegelsberg (Patrick N.J)

Company Executives of Picard Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Patrick N.J. Schnegelsberg
Mr. Patrick N.J. Schnegelsberg
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bernard Skaggs
Mr. Bernard Skaggs
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Matt Schuster
Mr. Matt Schuster
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Richard A. Fang, Ph.D.
Mr. Richard A. Fang, Ph.D.
Director
Director
--
--
Mr. Chris Hsieh
Mr. Chris Hsieh
Director
Director
--
--
Mr. Sam Van
Mr. Sam Van
Independent Director
Independent Director
--
--
Mr. George Ye
Mr. George Ye
Independent Director
Independent Director
--
--
Mr. Richard G. Smith
Mr. Richard G. Smith
Scientific Advisor, SynCardia
Scientific Advisor, SynCardia
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Patrick N.J. Schnegelsberg
Mr. Patrick N.J. Schnegelsberg
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bernard Skaggs
Mr. Bernard Skaggs
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Matt Schuster
Mr. Matt Schuster
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Richard A. Fang, Ph.D.
Mr. Richard A. Fang, Ph.D.
Director
Director
--
--
Mr. Chris Hsieh
Mr. Chris Hsieh
Director
Director
--
--
Mr. Sam Van
Mr. Sam Van
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
1.14M
95.96%
Europe
48.00K
4.04%
Rest of the world
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Feb 8
Updated: Sun, Feb 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hunniwell Picard I LLC
53.76%
Sindex SSI Financing LLC
10.78%
HRT Financial LP
0.33%
Citadel Advisors LLC
0.28%
Centiva Capital, LP
0.06%
Other
34.80%
Shareholders
Shareholders
Proportion
Hunniwell Picard I LLC
53.76%
Sindex SSI Financing LLC
10.78%
HRT Financial LP
0.33%
Citadel Advisors LLC
0.28%
Centiva Capital, LP
0.06%
Other
34.80%
Shareholder Types
Shareholders
Proportion
Corporation
64.53%
Investment Advisor
0.49%
Hedge Fund
0.35%
Venture Capital
0.02%
Other
34.60%

Institutional Shareholding

Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
8
536.21K
0.00%
--
2025Q4
12
636.03K
0.86%
+630.54K
2025Q3
2
47.56M
65.76%
+47.56M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Hunniwell Picard I LLC
39.62M
53.76%
--
--
Sep 26, 2025
Sindex SSI Financing LLC
7.94M
10.78%
--
--
Sep 26, 2025
HRT Financial LP
244.09K
0.33%
+244.09K
--
Sep 30, 2025
Citadel Advisors LLC
204.15K
0.28%
+204.15K
--
Sep 30, 2025
Centiva Capital, LP
42.42K
0.06%
+42.42K
--
Sep 30, 2025
UBS Financial Services, Inc.
5.48K
0.01%
+5.48K
--
Sep 30, 2025
XTX Markets LLC
17.74K
0.02%
+17.74K
--
Sep 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI